104 related articles for article (PubMed ID: 9804912)
21. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase.
Vanasse GJ; Halbrook J; Thomas S; Burgess A; Hoekstra MF; Disteche CM; Willerford DM
J Clin Invest; 1999 Jun; 103(12):1669-75. PubMed ID: 10377173
[TBL] [Abstract][Full Text] [Related]
22. In vivo transposition mediated by V(D)J recombinase in human T lymphocytes.
Messier TL; O'Neill JP; Hou SM; Nicklas JA; Finette BA
EMBO J; 2003 Mar; 22(6):1381-8. PubMed ID: 12628930
[TBL] [Abstract][Full Text] [Related]
23. Consistent breakage between consensus recombinase heptamers of chromosome 9 DNA in a recurrent chromosomal translocation of human T cell leukemia.
Tycko B; Reynolds TC; Smith SD; Sklar J
J Exp Med; 1989 Feb; 169(2):369-77. PubMed ID: 2536065
[TBL] [Abstract][Full Text] [Related]
24. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites.
Marculescu R; Le T; Simon P; Jaeger U; Nadel B
J Exp Med; 2002 Jan; 195(1):85-98. PubMed ID: 11781368
[TBL] [Abstract][Full Text] [Related]
25. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity.
Aplan PD; Lombardi DP; Ginsberg AM; Cossman J; Bertness VL; Kirsch IR
Science; 1990 Dec; 250(4986):1426-9. PubMed ID: 2255914
[TBL] [Abstract][Full Text] [Related]
26. Potential topoisomerase II DNA-binding sites at the breakpoints of a t(9;11) chromosome translocation in acute myeloid leukemia.
Negrini M; Felix CA; Martin C; Lange BJ; Nakamura T; Canaani E; Croce CM
Cancer Res; 1993 Oct; 53(19):4489-92. PubMed ID: 8402620
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous quantification of t(14;18) and HPRT exon 2/3 deletions in human lymphocytes.
Fuscoe JC
Methods Mol Biol; 2014; 1105():303-11. PubMed ID: 24623238
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of the t(10;14) translocation breakpoints in T-cell acute lymphoblastic leukemia: further evidence for illegitimate physiological recombination.
Lu M; Dubé I; Raimondi S; Carroll A; Zhao Y; Minden M; Sutherland P
Genes Chromosomes Cancer; 1990 Sep; 2(3):217-22. PubMed ID: 2078512
[TBL] [Abstract][Full Text] [Related]
29. V(D)J recombination activity in human hematopoietic cells: correlation with developmental stage and genome stability.
Gauss GH; Domain I; Hsieh CL; Lieber MR
Eur J Immunol; 1998 Jan; 28(1):351-8. PubMed ID: 9485214
[TBL] [Abstract][Full Text] [Related]
30. Molecular spectra of HPRT deletion mutations in circulating T-lymphocytes in Fanconi anemia patients.
Laquerbe A; Sala-Trepat M; Vives C; Escarceller M; Papadopoulo D
Mutat Res; 1999 Dec; 431(2):341-50. PubMed ID: 10635999
[TBL] [Abstract][Full Text] [Related]
31. Quantification of t(14;18) in the lymphocytes of healthy adult humans as a possible biomarker for environmental exposures to carcinogens.
Fuscoe JC; Setzer RW; Collard DD; Moore MM
Carcinogenesis; 1996 May; 17(5):1013-20. PubMed ID: 8640906
[TBL] [Abstract][Full Text] [Related]
32. Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia.
Meissner B; Bartram T; Eckert C; Trka J; Panzer-Grümayer R; Hermanova I; Ellinghaus E; Franke A; Möricke A; Schrauder A; Teigler-Schlegel A; Dörge P; von Stackelberg A; Basso G; Bartram CR; Kirschner-Schwabe R; Bornhäuser B; Bourquin JP; Cazzaniga G; Hauer J; Attarbaschi A; Izraeli S; Zaliova M; Cario G; Zimmermann M; Avigad S; Sokalska-Duhme M; Metzler M; Schrappe M; Koehler R; Te Kronnie G; Stanulla M
Hum Mol Genet; 2014 Feb; 23(3):590-601. PubMed ID: 24045615
[TBL] [Abstract][Full Text] [Related]
33. Sjögren's syndrome: lymphoma predisposition coupled with a reduced frequency of t(14;18) translocations in blood lymphocytes.
Henriksson G; Brant M; Sandor Z; Manthorpe R; Bredberg A
Mol Carcinog; 1999 Mar; 24(3):226-31. PubMed ID: 10204807
[TBL] [Abstract][Full Text] [Related]
34. Fine mapping of V(D)J recombinase mediated rearrangements in human lymphoid malignancies.
Halper-Stromberg E; Steranka J; Giraldo-Castillo N; Fuller T; Desiderio S; Burns KH
BMC Genomics; 2013 Aug; 14():565. PubMed ID: 23957733
[TBL] [Abstract][Full Text] [Related]
35. Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.
Tsuji H; Ishii-Ohba H; Katsube T; Ukai H; Aizawa S; Doi M; Hioki K; Ogiu T
Cancer Res; 2004 Dec; 64(24):8882-90. PubMed ID: 15604248
[TBL] [Abstract][Full Text] [Related]
36. Leukemia and lymphoma in ataxia telangiectasia.
Taylor AM; Metcalfe JA; Thick J; Mak YF
Blood; 1996 Jan; 87(2):423-38. PubMed ID: 8555463
[TBL] [Abstract][Full Text] [Related]
37. Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide.
Chen CL; Fuscoe JC; Liu Q; Pui CH; Mahmoud HH; Relling MV
J Natl Cancer Inst; 1996 Dec; 88(24):1840-7. PubMed ID: 8961974
[TBL] [Abstract][Full Text] [Related]
38. The t(8;14) chromosome translocation of the Burkitt lymphoma cell line Daudi occurred during immunoglobulin gene rearrangement and involved the heavy chain diversity region.
Haluska FG; Tsujimoto Y; Croce CM
Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6835-9. PubMed ID: 3116544
[TBL] [Abstract][Full Text] [Related]
39. V(D)J recombinase-mediated processing of coding junctions at cryptic recombination signal sequences in peripheral T cells during human development.
Murray JM; O'Neill JP; Messier T; Rivers J; Walker VE; McGonagle B; Trombley L; Cowell LG; Kelsoe G; McBlane F; Finette BA
J Immunol; 2006 Oct; 177(8):5393-404. PubMed ID: 17015725
[TBL] [Abstract][Full Text] [Related]
40. V(D)J targeting mistakes occur at low frequency in acute lymphoblastic leukemia.
Vanura K; Vrsalovic MM; Le T; Marculescu R; Kusec R; Jäger U; Nadel B
Genes Chromosomes Cancer; 2009 Aug; 48(8):725-36. PubMed ID: 19455608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
